Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MethylGene initiates dosing in second Phase I cancer trial
In this dose-escalating Phase I trial using a modified 3+3 design, MGCD265 is administered orally to patients at an initial starting dose of 24mg/m2 daily on a continuous
In this dose-escalating Phase I trial using a modified 3+3 design, MGCD265 is administered orally to patients at an initial starting dose of 24mg/m2 daily on a continuous
Under the terms of the agreement, China Sky One Medical’s wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, will acquire 100% of Jin Chuang’s assets
The joint venture (JV) between the companies is intended to be used as a vehicle for Synovics to have access to assets of Maneesh including personnel, drug development,
The first new Phase IIb clinical trial (Taski 2) will evaluate RA patients receiving 100mg of R788 PO bid (orally, twice daily) or 150mg PO qd (orally, once
Under the terms of the agreement, Lilly will obtain exclusive worldwide rights to TransPharma’s ViaDerm-hPTH (1-34) product and will also gain non-exclusive access to TransPharma’s ViaDerm drug delivery
GlaxoSmithKline’s Tyverb (lapatinib), in combination with capecitabine, is indicated for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress ErbB2. The authorization was based
The primary objective of this Phase I/II clinical trial was to determine the tolerability and safety profile of repeated administration of CTCE-9908. The secondary objective was to evaluate
The trial is designed to investigate two small molecule radiopharmaceutical candidates that target prostate-specific membrane antigen, MIP-1072 and MIP-1095, in order to select a lead candidate for further
This clinical trial comprises three discrete phases which allows for evaluation of efficacy and safety of Traficet-EN in inducing a clinical response or remission, as well as maintaining
Braemar’s ER920W is a digital loop recorder with on-board arrhythmia detection algorithms for automatic detection, recording and immediate transmission of patient data files to a service center for